HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"recordsFiltered": 49077,
"recordsTotal": 49077,
"next": null,
"previous": "http://staging-fdaaa.ebmdatalab.net/api/trials/?format=api&length=300&start=48600",
"results": [
{
"registry_id": "NCT06236724",
"publication_url": "https://clinicaltrials.gov/study/NCT06236724",
"title": "Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.",
"has_exemption": false,
"start_date": "2024-01-31",
"completion_date": "2033-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07060807",
"publication_url": "https://clinicaltrials.gov/study/NCT07060807",
"title": "An Open-label, Randomized, Phase 3 Study to Evaluate Patritumab Deruxtecan Monotherapy Versus Treatment of Physician's Choice in Hormone Receptor-positive, HER2-negative Unresectable Locally Advanced or Metastatic Breast Cancer (HERTHENA-Breast04)",
"has_exemption": false,
"start_date": "2025-07-21",
"completion_date": "2033-07-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07387926",
"publication_url": "https://clinicaltrials.gov/study/NCT07387926",
"title": "Open-label, Phase I/II Study to Evaluate Safety and Efficacy of Asciminib With Chemotherapy Followed by Asciminib Plus Blinatumomab in Pediatric, Adolescent, and Young Adults With Relapsed or Refractory BCR::ABL1-positive (Philadelphia Positive, Ph+) or BCR::ABL1-like (Ph-like) ALL",
"has_exemption": false,
"start_date": "2026-07-30",
"completion_date": "2033-07-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05803941",
"publication_url": "https://clinicaltrials.gov/study/NCT05803941",
"title": "A Phase IV, Post-Authorization Safety Study to Investigate the Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Adult Participants With Prostate Cancer",
"has_exemption": false,
"start_date": "2023-08-14",
"completion_date": "2033-07-20",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07393282",
"publication_url": "https://clinicaltrials.gov/study/NCT07393282",
"title": "A Phase 3, Randomized, Open-Label Study of Linvoseltamab Versus Daratumumab in Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-03-25",
"completion_date": "2033-07-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04510597",
"publication_url": "https://clinicaltrials.gov/study/NCT04510597",
"title": "Phase III Trial of Immunotherapy-Based Combination Therapy With or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial)",
"has_exemption": false,
"start_date": "2021-03-08",
"completion_date": "2033-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07015853",
"publication_url": "https://clinicaltrials.gov/study/NCT07015853",
"title": "IIT2024-02-SHIAO-ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2033-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stephen Shiao",
"sponsor_slug": "stephen-shiao",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07510334",
"publication_url": "https://clinicaltrials.gov/study/NCT07510334",
"title": "Phase 2 Clinical Evaluation of Combination Immunotherapy for Renal Cell Carcinoma",
"has_exemption": false,
"start_date": "2026-04-21",
"completion_date": "2033-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04984291",
"publication_url": "https://clinicaltrials.gov/study/NCT04984291",
"title": "Zimmer Biomet Shoulder Arthroplasty Long-term Post Market Clinical Follow-up Study",
"has_exemption": false,
"start_date": "2021-07-28",
"completion_date": "2033-08-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01736592",
"publication_url": "https://clinicaltrials.gov/study/NCT01736592",
"title": "An Open Label Study to Determine the Long Term Safety, Tolerability and Biological Activity of SAR422459 in Patients With Stargardt's Macular Degeneration",
"has_exemption": false,
"start_date": "2012-12-14",
"completion_date": "2033-08-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Sanofi",
"sponsor_slug": "sanofi",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07579910",
"publication_url": "https://clinicaltrials.gov/study/NCT07579910",
"title": "A Phase 3, Randomized, Single-blind, Parallel Group, Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of Intracerebroventricular Tralesinidase Alfa Treatment Compared to Standard of Care in Mucopolysaccharidosis Type IIIB (MPS IIIB, Sanfilippo Syndrome Type B)",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2033-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Spruce Biosciences",
"sponsor_slug": "spruce-biosciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07326592",
"publication_url": "https://clinicaltrials.gov/study/NCT07326592",
"title": "A Phase 4, Multicenter, Double-blind, Study to Investigate the Efficacy, Safety, and Tolerability of 3 Active Doses of Respreeza® / Zemaira® Weekly Intravenous Infusions Administered Over 3 Years as Longterm Maintenance Therapy in Adult Subjects With Emphysema Related to Alpha1 Antitrypsin Deficiency",
"has_exemption": false,
"start_date": "2026-07-20",
"completion_date": "2033-09-15",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06055712",
"publication_url": "https://clinicaltrials.gov/study/NCT06055712",
"title": "Antibiotic Prophylaxis in Pediatric Open Fractures",
"has_exemption": false,
"start_date": "2023-09-11",
"completion_date": "2033-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Louis University",
"sponsor_slug": "st-louis-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07192432",
"publication_url": "https://clinicaltrials.gov/study/NCT07192432",
"title": "A Phase 1/2, First-in-Human Study of VNX-202 Gene Therapy in Patients With HER2-Positive Cancer",
"has_exemption": false,
"start_date": "2025-11-18",
"completion_date": "2033-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vironexis Biotherapeutics Inc.",
"sponsor_slug": "vironexis-biotherapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07455851",
"publication_url": "https://clinicaltrials.gov/study/NCT07455851",
"title": "A FIH Phase 1/2 Study to Assess Safety, Tolerability, and Preliminary Anti-Tumor Activity of REGN17372, an Anti-GPRC5D x Anti-CD28 Costimulatory Bispecific Monoclonal Antibody, in Combination With Linvoseltamab, an Anti-BCMA x Anti-CD3 Bispecific Monoclonal Antibody, in Participants With Relapsed/Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-03-26",
"completion_date": "2033-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07624513",
"publication_url": "https://clinicaltrials.gov/study/NCT07624513",
"title": "Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-06-08",
"completion_date": "2033-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Dana-Farber Cancer Institute",
"sponsor_slug": "dana-farber-cancer-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07570173",
"publication_url": "https://clinicaltrials.gov/study/NCT07570173",
"title": "A Phase 2/3, Randomized, Open-Label, Comparison Study of MK-1045 Versus Blinatumomab in Participants With Relapsed or Refractory CD19+ B-Cell Acute Lymphoblastic Leukemia (B-ALL)",
"has_exemption": false,
"start_date": "2026-05-18",
"completion_date": "2033-10-18",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07080905",
"publication_url": "https://clinicaltrials.gov/study/NCT07080905",
"title": "Phase 3, Open-label, Single-dose, Multicenter Study Investigating Efficacy, Safety, and Tolerability of CSL222 (Etranacogene Dezaparvovec) Administered to Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2033-10-24",
"has_results": false,
"results_due": false,
"sponsor_name": "CSL Behring",
"sponsor_slug": "csl-behring",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04636190",
"publication_url": "https://clinicaltrials.gov/study/NCT04636190",
"title": "A Retrospectively Enrolled and Prospectively Followed, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Triathlon All-Polyethylene Tibia",
"has_exemption": false,
"start_date": "2021-07-02",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stryker Orthopaedics",
"sponsor_slug": "stryker-orthopaedics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05967351",
"publication_url": "https://clinicaltrials.gov/study/NCT05967351",
"title": "A Phase 3, Multinational, Long-term Follow-up Study to Evaluate Safety and Efficacy in Subjects Who Have Previously Received SRP-9001 in a Clinical Study",
"has_exemption": false,
"start_date": "2023-09-27",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sarepta Therapeutics, Inc.",
"sponsor_slug": "sarepta-therapeutics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05994235",
"publication_url": "https://clinicaltrials.gov/study/NCT05994235",
"title": "A Phase II Trial of Tazemetostat Plus Mosunetuzumab in Untreated Follicular Lymphoma",
"has_exemption": false,
"start_date": "2023-11-01",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06339320",
"publication_url": "https://clinicaltrials.gov/study/NCT06339320",
"title": "Endoscopic Sleeve Gastroplasty (ESG) for the Treatment of Obesity",
"has_exemption": false,
"start_date": "2024-02-28",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "The Methodist Hospital Research Institute",
"sponsor_slug": "the-methodist-hospital-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05660408",
"publication_url": "https://clinicaltrials.gov/study/NCT05660408",
"title": "RNA PRIME - RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors",
"has_exemption": false,
"start_date": "2025-03-12",
"completion_date": "2033-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03755739",
"publication_url": "https://clinicaltrials.gov/study/NCT03755739",
"title": "A Phase II/III Trial of Comparison of Benefit of Administration of Checkpoint Inhibitors Plus Chemodrug Via Artery or Fine Needle to Tumor Versus Vein for Immunotherapy of Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2018-11-01",
"completion_date": "2033-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Second Affiliated Hospital of Guangzhou Medical University",
"sponsor_slug": "second-affiliated-hospital-of-guangzhou-medical-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06368817",
"publication_url": "https://clinicaltrials.gov/study/NCT06368817",
"title": "A Phase II Trial Evaluating Chemotherapy Followed by Response-Based Reduced Radiation Therapy for Patients With Central Nervous System Germinomas",
"has_exemption": false,
"start_date": "2024-10-22",
"completion_date": "2033-11-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06669247",
"publication_url": "https://clinicaltrials.gov/study/NCT06669247",
"title": "A First-in-Human (FIH) Phase 1/2 Study to Assess Safety, Tolerability, and Preliminary Anti-Tumor Activity of REGN7945, an Anti-CD38 x Anti-CD28 Costimulatory Bispecific Monoclonal Antibody, in Combination With Linvoseltamab, an Anti-BCMA x Anti-CD3 Bispecific Monoclonal Antibody, in Participants With Relapsed/Refractory Multiple Myeloma",
"has_exemption": false,
"start_date": "2024-12-11",
"completion_date": "2033-11-11",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04742634",
"publication_url": "https://clinicaltrials.gov/study/NCT04742634",
"title": "A Phase I/II Trial of Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant",
"has_exemption": false,
"start_date": "2022-05-12",
"completion_date": "2033-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07058077",
"publication_url": "https://clinicaltrials.gov/study/NCT07058077",
"title": "An Operationally Seamless Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Enlicitide Decanoate in Pediatric Participants With Heterozygous Familial Hypercholesterolemia",
"has_exemption": false,
"start_date": "2025-08-21",
"completion_date": "2033-12-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05642195",
"publication_url": "https://clinicaltrials.gov/study/NCT05642195",
"title": "Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-06-11",
"completion_date": "2033-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04513717",
"publication_url": "https://clinicaltrials.gov/study/NCT04513717",
"title": "Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)",
"has_exemption": false,
"start_date": "2021-01-21",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NRG Oncology",
"sponsor_slug": "nrg-oncology",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04754087",
"publication_url": "https://clinicaltrials.gov/study/NCT04754087",
"title": "Global, Multicenter, and Prospective Post-Market Clinical Follow-Up Study of the G7 Acetabular System With Vivacit-E and Longevity Highly Crosslinked Polyethylene (HXLPE) Liners & Instrumentation",
"has_exemption": false,
"start_date": "2021-07-07",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220902",
"publication_url": "https://clinicaltrials.gov/study/NCT07220902",
"title": "Levetiracetam Compared to Magnesium Sulfate for Prevention of Eclamptic Seizure: A Randomized Controlled Trial \"LEVMag Trial\"",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nebraska Methodist Health System",
"sponsor_slug": "nebraska-methodist-health-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07549698",
"publication_url": "https://clinicaltrials.gov/study/NCT07549698",
"title": "A Phase 1/2 Dose Evaluation Trial of the Safety and Preliminary Efficacy of Anti CD19 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX112) in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "CRISPR Therapeutics AG",
"sponsor_slug": "crispr-therapeutics-ag",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07321847",
"publication_url": "https://clinicaltrials.gov/study/NCT07321847",
"title": "Intratumoral Injection of IP-001 Following Standard-of-care Complete Hepatic Tumor Ablation in Patients With Liver-only Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2033-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Immunophotonics, Inc.",
"sponsor_slug": "immunophotonics-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07405164",
"publication_url": "https://clinicaltrials.gov/study/NCT07405164",
"title": "A Multicenter, Open-label, Phase 3 Extension Study to Evaluate the Long-term Efficacy and Safety in Participants Who Are Currently on Treatment in a Belzutifan Study (LITESPARK-043)",
"has_exemption": false,
"start_date": "2026-03-23",
"completion_date": "2034-01-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02106988",
"publication_url": "https://clinicaltrials.gov/study/NCT02106988",
"title": "Concurrent Chemotherapy and Radiation Therapy for Newly Diagnosed Patients With Stage I/II Nasal NK Cell Lymphoma",
"has_exemption": false,
"start_date": "2015-01-16",
"completion_date": "2034-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06591819",
"publication_url": "https://clinicaltrials.gov/study/NCT06591819",
"title": "Safety of Hypofractionated Whole-Pelvis Proton Therapy With HDR Boost",
"has_exemption": false,
"start_date": "2025-01-15",
"completion_date": "2034-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Abramson Cancer Center at Penn Medicine",
"sponsor_slug": "abramson-cancer-center-at-penn-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07572929",
"publication_url": "https://clinicaltrials.gov/study/NCT07572929",
"title": "A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant",
"has_exemption": false,
"start_date": "2026-08-01",
"completion_date": "2034-02-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06312137",
"publication_url": "https://clinicaltrials.gov/study/NCT06312137",
"title": "A Phase 3 Randomized Open-Label Study of Adjuvant Pembrolizumab With or Without MK-2870 in Participants With Resectable Stage II to IIIB (N2) NSCLC Not Achieving pCR After Receiving Neoadjuvant Pembrolizumab With Platinum-based Doublet Chemotherapy Followed by Surgery",
"has_exemption": false,
"start_date": "2024-04-03",
"completion_date": "2034-02-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05552157",
"publication_url": "https://clinicaltrials.gov/study/NCT05552157",
"title": "A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled, Two-Stage Adaptive Design, Platform Trial of Investigational Treatments for Primary Prevention of Disease Progression in Dominantly Inherited Alzheimer's Disease",
"has_exemption": false,
"start_date": "2024-11-22",
"completion_date": "2034-03-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06337032",
"publication_url": "https://clinicaltrials.gov/study/NCT06337032",
"title": "An Open-label, Single-arm Study to Provide Continued Access to Study Drug to Participants Who Have Completed Pediatric Clinical Studies Involving Gilead HIV Treatments",
"has_exemption": false,
"start_date": "2024-08-27",
"completion_date": "2034-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Gilead Sciences",
"sponsor_slug": "gilead-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06647498",
"publication_url": "https://clinicaltrials.gov/study/NCT06647498",
"title": "A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled, Two-Stage Adaptive Design, Platform Trial of Investigational Treatments for Primary Prevention of Disease Progression in Dominantly Inherited Alzheimer's Disease",
"has_exemption": false,
"start_date": "2024-11-22",
"completion_date": "2034-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05144191",
"publication_url": "https://clinicaltrials.gov/study/NCT05144191",
"title": "Insignia™ Hip Stem Outcomes Study - A Prospective, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Insignia™ Hip Stem for Total Hip Replacement Surgery",
"has_exemption": false,
"start_date": "2022-02-07",
"completion_date": "2034-04-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Stryker Orthopaedics",
"sponsor_slug": "stryker-orthopaedics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05295433",
"publication_url": "https://clinicaltrials.gov/study/NCT05295433",
"title": "A Phase 1/2, Global, Open-Label, Extension Study to Evaluate the Long-Term Safety and Clinical Activity of mRNA-3705 in Participants Previously Enrolled in Other Clinical Studies of mRNA-3705",
"has_exemption": false,
"start_date": "2022-03-08",
"completion_date": "2034-04-02",
"has_results": false,
"results_due": false,
"sponsor_name": "ModernaTX, Inc.",
"sponsor_slug": "modernatx-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06628778",
"publication_url": "https://clinicaltrials.gov/study/NCT06628778",
"title": "Collaborative Risk-stratified Investigation in Thrombosis-prone Inpatients With Critical Illness: Anticoagulation With LMWH in Teens for ThromboProphylaxis (CRITICAL-Teens-TP)",
"has_exemption": false,
"start_date": "2027-04-15",
"completion_date": "2034-04-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Johns Hopkins All Children's Hospital",
"sponsor_slug": "johns-hopkins-all-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06559540",
"publication_url": "https://clinicaltrials.gov/study/NCT06559540",
"title": "SWIFT RT: Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer",
"has_exemption": false,
"start_date": "2024-08-27",
"completion_date": "2034-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06264388",
"publication_url": "https://clinicaltrials.gov/study/NCT06264388",
"title": "A Biomarker-Guided Phase 2 Study of DB107-RRV (Retroviral Replicating Vector) Combined With DB107-Flucytosine Extended-Release Tablets in Patients With Recurrent Glioblastoma or Anaplastic Astrocytoma",
"has_exemption": false,
"start_date": "2024-05-01",
"completion_date": "2034-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Ashish Shah",
"sponsor_slug": "ashish-shah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06400342",
"publication_url": "https://clinicaltrials.gov/study/NCT06400342",
"title": "Randomized Evaluation of Valve-In-Valve Versus Explantation for Failed TAVR (REVIVE-TAVR)",
"has_exemption": false,
"start_date": "2025-03-01",
"completion_date": "2034-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Medstar Health Research Institute",
"sponsor_slug": "medstar-health-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04817969",
"publication_url": "https://clinicaltrials.gov/study/NCT04817969",
"title": "Persona® Ti-Nidium® Personalized Total Knee System A Post-Market Clinical Follow-up Study to Provide Safety, Performance and Clinical Benefits Data Using the Persona Ti-Nidium Total Knee System and Instrumentation",
"has_exemption": false,
"start_date": "2021-06-01",
"completion_date": "2034-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06289673",
"publication_url": "https://clinicaltrials.gov/study/NCT06289673",
"title": "INITIALL: Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma",
"has_exemption": false,
"start_date": "2024-12-26",
"completion_date": "2034-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07339384",
"publication_url": "https://clinicaltrials.gov/study/NCT07339384",
"title": "Circulating Tumor DNA Assessment in Early-Stage Endometrial Cancer (SIGNAL-EMC 101)",
"has_exemption": false,
"start_date": "2026-05-31",
"completion_date": "2034-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Natera, Inc.",
"sponsor_slug": "natera-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06239272",
"publication_url": "https://clinicaltrials.gov/study/NCT06239272",
"title": "NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)",
"has_exemption": false,
"start_date": "2024-03-27",
"completion_date": "2034-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07548450",
"publication_url": "https://clinicaltrials.gov/study/NCT07548450",
"title": "A Phase II Study of Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER)",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2034-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05878769",
"publication_url": "https://clinicaltrials.gov/study/NCT05878769",
"title": "A Phase III Open-Label Extension Study to Evaluate the Long-Term Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease",
"has_exemption": false,
"start_date": "2023-06-28",
"completion_date": "2034-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07483632",
"publication_url": "https://clinicaltrials.gov/study/NCT07483632",
"title": "A Phase 3 Study With an Open-Label Extension in Pediatric Participants to Evaluate the Safety, Efficacy, and Pharmacokinetics of Diroximel Fumarate and Dimethyl Fumarate for the Treatment of Relapsing Forms of Multiple Sclerosis",
"has_exemption": false,
"start_date": "2026-11-16",
"completion_date": "2034-07-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Biogen",
"sponsor_slug": "biogen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02791581",
"publication_url": "https://clinicaltrials.gov/study/NCT02791581",
"title": "Understanding and Predicting Breast Cancer Events After Treatment (UPBEAT)",
"has_exemption": false,
"start_date": "2017-07-21",
"completion_date": "2034-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07071519",
"publication_url": "https://clinicaltrials.gov/study/NCT07071519",
"title": "A Phase 3, Multi-Center Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Risankizumab With Open-Label Induction, Randomized Double-Blind Maintenance, and Open-Label Long-Term Extension Periods in Pediatric Subjects (2 to < 18 Years of Age) With Moderately to Severely Active Ulcerative Colitis",
"has_exemption": false,
"start_date": "2025-07-28",
"completion_date": "2034-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07629206",
"publication_url": "https://clinicaltrials.gov/study/NCT07629206",
"title": "Post Marketing Data Collection on Use of ProSense® Cryoablation System With Adjuvant Endocrine Therapy for the Treatment of Patients With Low-Risk, Early-Stage Breast Cancer (ChoICE Trial)",
"has_exemption": false,
"start_date": "2026-07-31",
"completion_date": "2034-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "IceCure Medical Ltd.",
"sponsor_slug": "icecure-medical-ltd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05907759",
"publication_url": "https://clinicaltrials.gov/study/NCT05907759",
"title": "A Phase II Study of Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease",
"has_exemption": false,
"start_date": "2024-07-10",
"completion_date": "2034-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06379789",
"publication_url": "https://clinicaltrials.gov/study/NCT06379789",
"title": "A Two-Part Open-Label Study of REGV131-LNP1265, A CRISPR/Cas9 Based Coagulation Factor IX Gene Insertion Therapy in Participants With Hemophilia B",
"has_exemption": false,
"start_date": "2024-09-11",
"completion_date": "2034-08-14",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07513376",
"publication_url": "https://clinicaltrials.gov/study/NCT07513376",
"title": "A Phase 3, Randomized, Placebo-Controlled Study of Adjuvant Intismeran Autogene Plus Subcutaneous Pembrolizumab and Berahyaluronidase Alfa (MK-3475A) or Intismeran Autogene Monotherapy Versus Placebo in Participants With Completely Resected High-Risk Stage I Non-Small Cell Lung Cancer (INTerpath-014)",
"has_exemption": false,
"start_date": "2026-05-04",
"completion_date": "2034-08-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06569082",
"publication_url": "https://clinicaltrials.gov/study/NCT06569082",
"title": "CD34+ Selected Donor Cell Boost for Management of Poor Graft Function or Primary or Secondary Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation",
"has_exemption": false,
"start_date": "2024-10-31",
"completion_date": "2034-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "NYU Langone Health",
"sponsor_slug": "nyu-langone-health",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06085742",
"publication_url": "https://clinicaltrials.gov/study/NCT06085742",
"title": "BRE-08: A Phase II Study of an All-Oral Adjuvant Chemotherapy Regimen of Cyclophosphamide, Methotrexate, and Capecitabine (CMC) for Early-Stage Breast Cancer",
"has_exemption": false,
"start_date": "2023-11-22",
"completion_date": "2034-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Illinois at Chicago",
"sponsor_slug": "university-of-illinois-at-chicago",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05977036",
"publication_url": "https://clinicaltrials.gov/study/NCT05977036",
"title": "BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer",
"has_exemption": false,
"start_date": "2024-09-25",
"completion_date": "2034-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07616154",
"publication_url": "https://clinicaltrials.gov/study/NCT07616154",
"title": "Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2034-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07221565",
"publication_url": "https://clinicaltrials.gov/study/NCT07221565",
"title": "ImmuneNet: Quantum-Synaptic Immunotherapy Mapping",
"has_exemption": false,
"start_date": "2025-10-23",
"completion_date": "2034-10-23",
"has_results": false,
"results_due": false,
"sponsor_name": "Truway Health, Inc.",
"sponsor_slug": "truway-health-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06023641",
"publication_url": "https://clinicaltrials.gov/study/NCT06023641",
"title": "A Protocol for the Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease",
"has_exemption": false,
"start_date": "2024-03-13",
"completion_date": "2034-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07291102",
"publication_url": "https://clinicaltrials.gov/study/NCT07291102",
"title": "Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma",
"has_exemption": false,
"start_date": "2026-07-01",
"completion_date": "2034-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Nationwide Children's Hospital",
"sponsor_slug": "nationwide-childrens-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06351631",
"publication_url": "https://clinicaltrials.gov/study/NCT06351631",
"title": "A Multicenter, Open-Label, Extension Study Evaluating the Safety and Efficacy of Bomedemstat for the Treatment of Participants Enrolled in a Prior Bomedemstat Clinical Study",
"has_exemption": false,
"start_date": "2024-05-23",
"completion_date": "2034-12-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06764095",
"publication_url": "https://clinicaltrials.gov/study/NCT06764095",
"title": "CAST-AI: Cystectomy After Systemic Therapy With ADC and Immunotherapy",
"has_exemption": false,
"start_date": "2025-01-08",
"completion_date": "2034-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06851767",
"publication_url": "https://clinicaltrials.gov/study/NCT06851767",
"title": "Phase 1/2 Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy",
"has_exemption": false,
"start_date": "2025-05-09",
"completion_date": "2034-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06926634",
"publication_url": "https://clinicaltrials.gov/study/NCT06926634",
"title": "Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)",
"has_exemption": false,
"start_date": "2025-12-09",
"completion_date": "2034-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07256977",
"publication_url": "https://clinicaltrials.gov/study/NCT07256977",
"title": "A Multicenter Non-inferiority Randomized Controlled Trial on Minimally Invasive Radical Hysterectomy Using an Endoscopic Stapler to Prevent Tumor Spillage in Stage IB2-IIA1 Cervical Cancer",
"has_exemption": false,
"start_date": "2026-01-01",
"completion_date": "2034-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Seoul National University Hospital",
"sponsor_slug": "seoul-national-university-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07428993",
"publication_url": "https://clinicaltrials.gov/study/NCT07428993",
"title": "A Phase II Study Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma",
"has_exemption": false,
"start_date": "2026-06-30",
"completion_date": "2034-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05307146",
"publication_url": "https://clinicaltrials.gov/study/NCT05307146",
"title": "Study of Brain Activity in Candidates for Epilepsy Surgery",
"has_exemption": false,
"start_date": "2013-12-18",
"completion_date": "2035-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Universitaire Ziekenhuizen KU Leuven",
"sponsor_slug": "universitaire-ziekenhuizen-ku-leuven",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07231471",
"publication_url": "https://clinicaltrials.gov/study/NCT07231471",
"title": "Platelet Rich Plasma for Musculoskeletal Conditions",
"has_exemption": false,
"start_date": "2025-12-29",
"completion_date": "2035-01-01",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Utah",
"sponsor_slug": "university-of-utah",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06820736",
"publication_url": "https://clinicaltrials.gov/study/NCT06820736",
"title": "A Prospective, Randomized Comparison Of Drainage Techniques After One- Or Two-Level Open Posterior Lumbar Decompression Or Decompression And Fusion",
"has_exemption": false,
"start_date": "2025-01-10",
"completion_date": "2035-01-09",
"has_results": false,
"results_due": false,
"sponsor_name": "Twin Cities Spine Center",
"sponsor_slug": "twin-cities-spine-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06826612",
"publication_url": "https://clinicaltrials.gov/study/NCT06826612",
"title": "A Phase 1/2, Randomized, Sequential, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of a One-Time, Bilateral, Intraparenchymal Infusion of SPK-10001 Into the Caudate and Putamen in Participants With Huntington's Disease",
"has_exemption": false,
"start_date": "2025-02-21",
"completion_date": "2035-01-12",
"has_results": false,
"results_due": false,
"sponsor_name": "Hoffmann-La Roche",
"sponsor_slug": "hoffmann-la-roche",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06096844",
"publication_url": "https://clinicaltrials.gov/study/NCT06096844",
"title": "A Randomized Phase III Trial of Chemo-Immunotherapy vs Immunotherapy Alone for the Vulnerable Older Adult With Advanced Non-Small Cell Lung Cancer: The ACHIEVE Study",
"has_exemption": false,
"start_date": "2024-07-19",
"completion_date": "2035-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07444723",
"publication_url": "https://clinicaltrials.gov/study/NCT07444723",
"title": "A Phase II Study of Accuracy of 18F-Fluorocholine PET/MRI and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors",
"has_exemption": false,
"start_date": "2026-04-16",
"completion_date": "2035-02-05",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04174105",
"publication_url": "https://clinicaltrials.gov/study/NCT04174105",
"title": "A Phase 1/2, Open-Label, Ascending-Dose Clinical Study to Evaluate the Safety and Preliminary Efficacy of AT845, an AAV8-Delivered Gene Transfer Therapy in Patients With Late Onset Pompe Disease",
"has_exemption": false,
"start_date": "2020-10-27",
"completion_date": "2035-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Astellas Gene Therapies",
"sponsor_slug": "astellas-gene-therapies",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07597070",
"publication_url": "https://clinicaltrials.gov/study/NCT07597070",
"title": "Universal Immunization to Fortify Immunotherapy Efficacy and Response (UNIFIER)",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2035-03-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Florida",
"sponsor_slug": "university-of-florida",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07526753",
"publication_url": "https://clinicaltrials.gov/study/NCT07526753",
"title": "Focused Shockwave (ESWT), Radial Pressure Waves (EPAT), And Electromagnetic Transduction Therapy (EMTT) For Lower Extremity Musculoskeletal Injuries",
"has_exemption": false,
"start_date": "2026-03-15",
"completion_date": "2035-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06931301",
"publication_url": "https://clinicaltrials.gov/study/NCT06931301",
"title": "Effect of Hyperbaric Oxygen Therapy on Osteonecrosis of the Femoral Head When Combined With 3D Navigated Core Decompression With Bone Marrow Aspirate Concentrate",
"has_exemption": false,
"start_date": "2026-03-31",
"completion_date": "2035-04-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yale University",
"sponsor_slug": "yale-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06412497",
"publication_url": "https://clinicaltrials.gov/study/NCT06412497",
"title": "MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.",
"has_exemption": false,
"start_date": "2024-06-05",
"completion_date": "2035-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Masonic Cancer Center, University of Minnesota",
"sponsor_slug": "masonic-cancer-center-university-of-minnesota",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06037356",
"publication_url": "https://clinicaltrials.gov/study/NCT06037356",
"title": "Prostatic Urethral Lift Versus Transurethral Resection of Prostate in Benign Prostatic Hyperplasia Patients With Urinary Retention",
"has_exemption": false,
"start_date": "2025-01-01",
"completion_date": "2035-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Queen Mary Hospital, Hong Kong",
"sponsor_slug": "queen-mary-hospital-hong-kong",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02800486",
"publication_url": "https://clinicaltrials.gov/study/NCT02800486",
"title": "Phase II Trial of Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory Glioblastoma Multiforme, Anaplastic Astrocytoma, and Anaplastic Oligoastrocytoma",
"has_exemption": false,
"start_date": "2016-05-31",
"completion_date": "2035-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwell Health",
"sponsor_slug": "northwell-health",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02177721",
"publication_url": "https://clinicaltrials.gov/study/NCT02177721",
"title": "A Field Study to Evaluate the Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario",
"has_exemption": false,
"start_date": "2027-01-31",
"completion_date": "2035-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Emergent BioSolutions",
"sponsor_slug": "emergent-biosolutions",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04731077",
"publication_url": "https://clinicaltrials.gov/study/NCT04731077",
"title": "Global, Multicenter, and Prospective Post-Market Clinical Follow-Up Study of the Avenir Complete™ Femoral Stem (Implants and Instrumentation)",
"has_exemption": false,
"start_date": "2021-09-27",
"completion_date": "2035-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03167437",
"publication_url": "https://clinicaltrials.gov/study/NCT03167437",
"title": "An Open-Label, Proof of Concept Study of Vorinostat for the Treatment of Moderate-to-Severe Crohn's Disease, Ulcerative Colitis, and Chronic Granulomatous Disease Colitis Patients and Maintenance Therapy With Ustekinumab",
"has_exemption": false,
"start_date": "2017-10-30",
"completion_date": "2035-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Allergy and Infectious Diseases (NIAID)",
"sponsor_slug": "national-institute-of-allergy-and-infectious-diseases-niaid",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06422806",
"publication_url": "https://clinicaltrials.gov/study/NCT06422806",
"title": "A Randomized Phase III Trial of Doxorubicin + Pembrolizumab Versus Doxorubicin Alone for the Treatment of Dedifferentiated Liposarcoma (DDLPS), Undifferentiated Pleomorphic Sarcoma (UPS) and Related Poorly Differentiated Sarcomas",
"has_exemption": false,
"start_date": "2024-09-11",
"completion_date": "2035-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06728072",
"publication_url": "https://clinicaltrials.gov/study/NCT06728072",
"title": "Pilot Study Evaluating Microbiome Modulation Therapy (MBMT) With Ciprofloxacin, Metronidazole, and Aspirin in Addition to Standard of Care Chemotherapy in Patients Undergoing First-Line Therapy for Metastatic Colorectal Cancer",
"has_exemption": false,
"start_date": "2025-03-07",
"completion_date": "2035-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Virginia Commonwealth University",
"sponsor_slug": "virginia-commonwealth-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05535166",
"publication_url": "https://clinicaltrials.gov/study/NCT05535166",
"title": "SJiMB21: Phase 2 Study of Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma",
"has_exemption": false,
"start_date": "2022-12-20",
"completion_date": "2035-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06814145",
"publication_url": "https://clinicaltrials.gov/study/NCT06814145",
"title": "A Phase 2, Multicenter, Double-blind, Extension Study to Evaluate the Effects of Sotatercept for the Treatment of Combined Postcapillary and Precapillary Pulmonary Hypertension (Cpc-PH) Due to Heart Failure With Preserved Ejection Fraction (HFpEF)",
"has_exemption": false,
"start_date": "2025-04-16",
"completion_date": "2035-08-10",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01654133",
"publication_url": "https://clinicaltrials.gov/study/NCT01654133",
"title": "Evaluation of Visceral Function Following Endovascular Aortic Aneurysm Repair Using Branched Stent- Grafts",
"has_exemption": false,
"start_date": "2012-07-31",
"completion_date": "2035-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of North Carolina, Chapel Hill",
"sponsor_slug": "university-of-north-carolina-chapel-hill",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07005024",
"publication_url": "https://clinicaltrials.gov/study/NCT07005024",
"title": "A Comparison of Anticoagulant Dosing Strategies to Reduce VTE and Mortality in Cancer Outpatients: A Randomized, Pragmatic Trial",
"has_exemption": false,
"start_date": "2025-10-17",
"completion_date": "2035-08-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Vermont",
"sponsor_slug": "university-of-vermont",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06995053",
"publication_url": "https://clinicaltrials.gov/study/NCT06995053",
"title": "Image-Guidance With Triggered Beam Hold To Implanted Fiducial Markers or Hypersight for Stereotactic Body Radiotherapy for Prostate Cancer (ILLUSION)",
"has_exemption": false,
"start_date": "2025-06-27",
"completion_date": "2035-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07072585",
"publication_url": "https://clinicaltrials.gov/study/NCT07072585",
"title": "A Phase 2/3 Randomized Trial Investigating Daratumumab on a Modified Augmented BFM (aBFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LL)",
"has_exemption": false,
"start_date": "2026-06-28",
"completion_date": "2035-09-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's Oncology Group",
"sponsor_slug": "childrens-oncology-group",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07552181",
"publication_url": "https://clinicaltrials.gov/study/NCT07552181",
"title": "Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer",
"has_exemption": false,
"start_date": "2026-09-30",
"completion_date": "2035-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Yuan Yuan",
"sponsor_slug": "yuan-yuan",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07053436",
"publication_url": "https://clinicaltrials.gov/study/NCT07053436",
"title": "MMRC Horizon Two: A Phase II Randomized Adaptive Platform Trial Integrating Novel Therapies in High-Risk-Newly Diagnosed Multiple Myeloma (MMRC-100)",
"has_exemption": false,
"start_date": "2026-04-30",
"completion_date": "2035-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Multiple Myeloma Research Consortium",
"sponsor_slug": "multiple-myeloma-research-consortium",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07220187",
"publication_url": "https://clinicaltrials.gov/study/NCT07220187",
"title": "A Randomized Phase III Study of Pirtobrutinib Plus R-CHOP vs. R-CHOP for Participants With Previously Untreated Richter Transformation (PIRAMID)",
"has_exemption": false,
"start_date": "2026-05-02",
"completion_date": "2035-10-01",
"has_results": false,
"results_due": false,
"sponsor_name": "SWOG Cancer Research Network",
"sponsor_slug": "swog-cancer-research-network",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07185165",
"publication_url": "https://clinicaltrials.gov/study/NCT07185165",
"title": "Eclipse: Flotufolastat F 18 to Determine Treatment Success Following Prostate Focal Therapy",
"has_exemption": false,
"start_date": "2025-10-09",
"completion_date": "2035-10-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05128903",
"publication_url": "https://clinicaltrials.gov/study/NCT05128903",
"title": "Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study",
"has_exemption": false,
"start_date": "2022-07-05",
"completion_date": "2035-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "St. Jude Children's Research Hospital",
"sponsor_slug": "st-jude-childrens-research-hospital",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03841617",
"publication_url": "https://clinicaltrials.gov/study/NCT03841617",
"title": "The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer",
"has_exemption": false,
"start_date": "2019-07-29",
"completion_date": "2035-11-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
"sponsor_slug": "national-institute-of-diabetes-and-digestive-and-kidney-diseases-niddk",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05828511",
"publication_url": "https://clinicaltrials.gov/study/NCT05828511",
"title": "Phase 1/2 Study of Linvoseltamab (Anti-BCMA X Anti-CD3 Bispecific Antibody) in Previously Untreated Patients With Symptomatic Multiple Myeloma",
"has_exemption": false,
"start_date": "2023-12-19",
"completion_date": "2035-11-02",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03371212",
"publication_url": "https://clinicaltrials.gov/study/NCT03371212",
"title": "A Prospective Randomized Trial of Modular Dual Mobility Acetabular Components Versus Conventional Single Bearing Components in Primary Total Hip Arthroplasty",
"has_exemption": false,
"start_date": "2017-12-15",
"completion_date": "2035-12-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Rush University Medical Center",
"sponsor_slug": "rush-university-medical-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07293585",
"publication_url": "https://clinicaltrials.gov/study/NCT07293585",
"title": "Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment",
"has_exemption": false,
"start_date": "2025-12-16",
"completion_date": "2035-12-16",
"has_results": false,
"results_due": false,
"sponsor_name": "Jonsson Comprehensive Cancer Center",
"sponsor_slug": "jonsson-comprehensive-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06701760",
"publication_url": "https://clinicaltrials.gov/study/NCT06701760",
"title": "Exogenous Sodium Lactate Infusion in Traumatic Brain Injury (ELI-TBI)",
"has_exemption": false,
"start_date": "2028-01-10",
"completion_date": "2035-12-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Los Angeles",
"sponsor_slug": "university-of-california-los-angeles",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04699591",
"publication_url": "https://clinicaltrials.gov/study/NCT04699591",
"title": "Compassionate Use of Domperidone for Refractory Gastroparesis",
"has_exemption": false,
"start_date": "2013-04-30",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jose Cocjin",
"sponsor_slug": "jose-cocjin",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02469662",
"publication_url": "https://clinicaltrials.gov/study/NCT02469662",
"title": "Retrospective and Prospective Clinical Outcomes Study of the Zimmer® Nexel™ Total Elbow",
"has_exemption": false,
"start_date": "2015-06-30",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04042025",
"publication_url": "https://clinicaltrials.gov/study/NCT04042025",
"title": "A Long-term Follow-up Study of Patients in the Clinical Trials for Spinal Muscular Atrophy Receiving AVXS-101",
"has_exemption": false,
"start_date": "2020-02-10",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Gene Therapies",
"sponsor_slug": "novartis-gene-therapies",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06697301",
"publication_url": "https://clinicaltrials.gov/study/NCT06697301",
"title": "A Multicenter, Randomized, Double-Blind, Active Comparator-Controlled, Adaptive Phase 2/3 Study to Evaluate the Safety and Efficacy of EIK1001 and Pembrolizumab Versus Placebo and Pembrolizumab as First-Line Therapy in Participants With Advanced Melanoma (TeLuRide-006)",
"has_exemption": false,
"start_date": "2025-05-22",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eikon Therapeutics",
"sponsor_slug": "eikon-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07282834",
"publication_url": "https://clinicaltrials.gov/study/NCT07282834",
"title": "Randomized Phase II Trial of Heated Vs. Pressurized/Aerosolized Chemotherapy (HIPEC vs. PIPAC) for Peritoneal Carcinomatosis",
"has_exemption": false,
"start_date": "2026-01-05",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Patrick Wagner, MD, FACS",
"sponsor_slug": "patrick-wagner-md-facs",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07186634",
"publication_url": "https://clinicaltrials.gov/study/NCT07186634",
"title": "Domain-Specific Appendix: OXYGEN",
"has_exemption": false,
"start_date": "2026-04-06",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Monash University",
"sponsor_slug": "monash-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07447076",
"publication_url": "https://clinicaltrials.gov/study/NCT07447076",
"title": "A Platform Study of Novel Therapies for Children, Adolescents and Young Adults With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)",
"has_exemption": false,
"start_date": "2026-05-01",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sabine Mueller, MD, PhD",
"sponsor_slug": "sabine-mueller-md-phd",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07365319",
"publication_url": "https://clinicaltrials.gov/study/NCT07365319",
"title": "A Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2/3 Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer (TeLuRide-008).",
"has_exemption": false,
"start_date": "2026-05-18",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Eikon Therapeutics",
"sponsor_slug": "eikon-therapeutics",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07240649",
"publication_url": "https://clinicaltrials.gov/study/NCT07240649",
"title": "Emerging Indications for Hyperbaric Oxygen Treatment",
"has_exemption": false,
"start_date": "2026-08-31",
"completion_date": "2035-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Jay C. Buckey Jr.",
"sponsor_slug": "jay-c-buckey-jr",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04074135",
"publication_url": "https://clinicaltrials.gov/study/NCT04074135",
"title": "Evaluation of the Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors",
"has_exemption": false,
"start_date": "2020-06-02",
"completion_date": "2036-01-30",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07308886",
"publication_url": "https://clinicaltrials.gov/study/NCT07308886",
"title": "Phase II Study of Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-response (REGIMEN-KS HIV)",
"has_exemption": false,
"start_date": "2026-04-08",
"completion_date": "2036-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02445222",
"publication_url": "https://clinicaltrials.gov/study/NCT02445222",
"title": "Long Term Follow-Up of Patients Exposed to Lentiviral-Based CAR T-Cell Therapy",
"has_exemption": false,
"start_date": "2015-11-02",
"completion_date": "2036-02-22",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06892522",
"publication_url": "https://clinicaltrials.gov/study/NCT06892522",
"title": "A Phase 1/2, Open-Label, Platform Study to Evaluate Safety and Efficacy of Etentamig Monotherapy or Etentamig Combinations in Subjects With Multiple Myeloma",
"has_exemption": false,
"start_date": "2025-06-30",
"completion_date": "2036-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05767047",
"publication_url": "https://clinicaltrials.gov/study/NCT05767047",
"title": "A Phase 3, Multicenter, Open-label, Long-term Extension Study of Apremilast in Children 2 Years of Age or Older With Oral Ulcers Associated With Behçet's Disease or 5 Years of Age or Older With Juvenile Psoriatic Arthritis",
"has_exemption": false,
"start_date": "2023-03-23",
"completion_date": "2036-03-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07420959",
"publication_url": "https://clinicaltrials.gov/study/NCT07420959",
"title": "Phase 1/2 Trial of ABBV-383 for Patients With Relapsed Refractory Waldenström Macroglobulinemia",
"has_exemption": false,
"start_date": "2026-03-25",
"completion_date": "2036-03-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02201992",
"publication_url": "https://clinicaltrials.gov/study/NCT02201992",
"title": "A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein",
"has_exemption": false,
"start_date": "2015-03-23",
"completion_date": "2036-05-01",
"has_results": false,
"results_due": false,
"sponsor_name": "ECOG-ACRIN Cancer Research Group",
"sponsor_slug": "ecog-acrin-cancer-research-group",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT03955445",
"publication_url": "https://clinicaltrials.gov/study/NCT03955445",
"title": "An Open-label, Non-randomized Extension Study to Evaluate the Long-term Efficacy, Safety and Tolerability of Iptacopan (LNP023) in C3 Glomerulopathy or Idiopathic Immune-complex-membranoproliferative Glomerulonephritis",
"has_exemption": false,
"start_date": "2019-10-03",
"completion_date": "2036-05-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Novartis Pharmaceuticals",
"sponsor_slug": "novartis-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06918002",
"publication_url": "https://clinicaltrials.gov/study/NCT06918002",
"title": "A Phase 3, Open-label, Controlled, Randomized Study of Newly Diagnosed Multiple Myeloma Treatment, Designed to Evaluate the Efficacy and Safety of the Elranatamab-lenalidomide Combination as a Replacement for Chemotherapy Followed by Autologous Stem Cell Transplant in the Consolidation Phase, and to Compare Elranatamab With Standard of Care in the Maintenance Phase",
"has_exemption": false,
"start_date": "2025-07-09",
"completion_date": "2036-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Intergroupe Francophone du Myelome",
"sponsor_slug": "intergroupe-francophone-du-myelome",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07250477",
"publication_url": "https://clinicaltrials.gov/study/NCT07250477",
"title": "Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2026-01-30",
"completion_date": "2036-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, Davis",
"sponsor_slug": "university-of-california-davis",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07393373",
"publication_url": "https://clinicaltrials.gov/study/NCT07393373",
"title": "Phase 2, Open-Label, Long-Term, Extension (OLE) Study of Infigratinib, an FGFR 1-3-Selective Tyrosine Kinase Inhibitor, in Children With Hypochondroplasia: ACCEL OLE",
"has_exemption": false,
"start_date": "2026-04-23",
"completion_date": "2036-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "QED Therapeutics, a BridgeBio company",
"sponsor_slug": "qed-therapeutics-a-bridgebio-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05441813",
"publication_url": "https://clinicaltrials.gov/study/NCT05441813",
"title": "A Randomized, Open-label Study of Coconut Oil Mouth Rinse for Prophylaxis of Severe Oral Mucositis in Pediatric Patients Receiving Myeloablative Conditioning Regimens",
"has_exemption": false,
"start_date": "2023-02-15",
"completion_date": "2036-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Wake Forest University Health Sciences",
"sponsor_slug": "wake-forest-university-health-sciences",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06342999",
"publication_url": "https://clinicaltrials.gov/study/NCT06342999",
"title": "Evaluation of Outcomes of Fetal Aortic Valvuloplasty for Evolving Hypoplastic Left Heart Syndrome",
"has_exemption": false,
"start_date": "2027-01-01",
"completion_date": "2036-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mauro H. Schenone",
"sponsor_slug": "mauro-h-schenone",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03435796",
"publication_url": "https://clinicaltrials.gov/study/NCT03435796",
"title": "Long-Term Follow-up Protocol for Subjects Treated With Gene-Modified T Cells",
"has_exemption": false,
"start_date": "2018-07-19",
"completion_date": "2036-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Celgene",
"sponsor_slug": "celgene",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06072482",
"publication_url": "https://clinicaltrials.gov/study/NCT06072482",
"title": "A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of Avacopan in Participants With Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis",
"has_exemption": false,
"start_date": "2024-02-07",
"completion_date": "2036-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Amgen",
"sponsor_slug": "amgen",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05669846",
"publication_url": "https://clinicaltrials.gov/study/NCT05669846",
"title": "Phase II Feasibility Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC",
"has_exemption": false,
"start_date": "2025-01-08",
"completion_date": "2036-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Diwakar Davar",
"sponsor_slug": "diwakar-davar",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06974279",
"publication_url": "https://clinicaltrials.gov/study/NCT06974279",
"title": "Precision Neuromodulation in Post-Stroke Aphasia Using TMS",
"has_exemption": false,
"start_date": "2025-09-01",
"completion_date": "2036-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Medical College of Wisconsin",
"sponsor_slug": "medical-college-of-wisconsin",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06932562",
"publication_url": "https://clinicaltrials.gov/study/NCT06932562",
"title": "A Randomized, Open-Label, Controlled Phase 3 Study of Comparing Daratumumab, Lenalidomide and Dexamethasone Induction Followed by Linvoseltamab Versus Continued Daratumumab, Lenalidomide, and Dexamethasone in Newly Diagnosed Transplant Ineligible Multiple Myeloma Patients",
"has_exemption": false,
"start_date": "2025-12-23",
"completion_date": "2036-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "European Myeloma Network B.V.",
"sponsor_slug": "european-myeloma-network-bv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05548972",
"publication_url": "https://clinicaltrials.gov/study/NCT05548972",
"title": "Global, Multicenter and Prospective Post-Market Clinical Follow-Up Study of the G7® Dual Mobility Acetabular System With Vivacit-E® or Longevity® Poly Bearing & Instrumentation",
"has_exemption": false,
"start_date": "2023-03-20",
"completion_date": "2037-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06938399",
"publication_url": "https://clinicaltrials.gov/study/NCT06938399",
"title": "Motiva Implants® Post-Approval Study (PAS) Protocol for Motiva SmoothSilk® Round Ergonomix® ('Ergonomix®') and SmoothSilk® Round ('Round') Breast Implants in Subjects Who Are Undergoing Primary Breast Augmentation, Revision Augmentation and Other Aesthetic Procedures",
"has_exemption": false,
"start_date": "2025-05-01",
"completion_date": "2037-04-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Motiva USA LLC",
"sponsor_slug": "motiva-usa-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03935893",
"publication_url": "https://clinicaltrials.gov/study/NCT03935893",
"title": "A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Advanced Solid Cancers",
"has_exemption": false,
"start_date": "2019-12-03",
"completion_date": "2037-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Udai Kammula",
"sponsor_slug": "udai-kammula",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05201781",
"publication_url": "https://clinicaltrials.gov/study/NCT05201781",
"title": "Long-term Follow-up Study for Participants Previously Treated With Ciltacabtagene Autoleucel",
"has_exemption": false,
"start_date": "2022-03-09",
"completion_date": "2037-07-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Janssen Research & Development, LLC",
"sponsor_slug": "janssen-research-development-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06986382",
"publication_url": "https://clinicaltrials.gov/study/NCT06986382",
"title": "Phase 1b/2a Trial of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) From an HLA-partially Matched Related or Unrelated Donor After TCRab+ T-cell/CD19+ B-cell Depletion for Patients With Monogenic and/or Early-onset (EO), Medically Refractory (MR) Crohn Disease (CD)",
"has_exemption": false,
"start_date": "2025-07-31",
"completion_date": "2037-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Stanford University",
"sponsor_slug": "stanford-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05281809",
"publication_url": "https://clinicaltrials.gov/study/NCT05281809",
"title": "A Feasibility Study Following a Phase 2a Design to Demonstrate Successful Local Manufacture of Chimeric Antigen Receptor (CAR) T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia",
"has_exemption": false,
"start_date": "2022-04-19",
"completion_date": "2037-08-05",
"has_results": false,
"results_due": false,
"sponsor_name": "John Lister",
"sponsor_slug": "john-lister",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07214532",
"publication_url": "https://clinicaltrials.gov/study/NCT07214532",
"title": "SIgnatera-Guided Initiation of Adjuvant CDK4/6 Inhibitor in Intermediate Risk HR+ HER2- Breast Cancer",
"has_exemption": false,
"start_date": "2026-03-24",
"completion_date": "2037-11-15",
"has_results": false,
"results_due": false,
"sponsor_name": "Natera, Inc.",
"sponsor_slug": "natera-inc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06191744",
"publication_url": "https://clinicaltrials.gov/study/NCT06191744",
"title": "A Phase 3, Multicenter, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of Epcoritamab + Rituximab and Lenalidomide (R2) Compared to Chemoimmunotherapy in Previously Untreated Follicular Lymphoma (EPCORE™FL-2)",
"has_exemption": false,
"start_date": "2024-02-05",
"completion_date": "2037-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Genmab",
"sponsor_slug": "genmab",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07116473",
"publication_url": "https://clinicaltrials.gov/study/NCT07116473",
"title": "A Phase 3, Open-Label, Multicenter, Extension Study of Acoramidis in Patients With Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy (ACT-EARLY OLE)",
"has_exemption": false,
"start_date": "2025-11-30",
"completion_date": "2037-11-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Eidos Therapeutics, a BridgeBio company",
"sponsor_slug": "eidos-therapeutics-a-bridgebio-company",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06651281",
"publication_url": "https://clinicaltrials.gov/study/NCT06651281",
"title": "A Phase 3 Extension Study to Evaluate the Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis",
"has_exemption": false,
"start_date": "2024-11-25",
"completion_date": "2037-12-17",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05587244",
"publication_url": "https://clinicaltrials.gov/study/NCT05587244",
"title": "Multicenter, Prospective Post-Market Clinical Follow-Up Study of the G7® Freedom Constrained Vivacit-E® Liners",
"has_exemption": false,
"start_date": "2023-05-08",
"completion_date": "2037-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Zimmer Biomet",
"sponsor_slug": "zimmer-biomet",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01770418",
"publication_url": "https://clinicaltrials.gov/study/NCT01770418",
"title": "A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer",
"has_exemption": false,
"start_date": "2013-03-31",
"completion_date": "2038-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Proton Collaborative Group",
"sponsor_slug": "proton-collaborative-group",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04192591",
"publication_url": "https://clinicaltrials.gov/study/NCT04192591",
"title": "A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE)",
"has_exemption": false,
"start_date": "2020-01-30",
"completion_date": "2038-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Boston Scientific Corporation",
"sponsor_slug": "boston-scientific-corporation",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07428369",
"publication_url": "https://clinicaltrials.gov/study/NCT07428369",
"title": "A Phase 2/3, Open-Label, Randomized Study of Linvoseltamab, Bortezomib and Lenalidomide (Linvo-VR) With and Without Autologous Stem Cell Transplantation (ASCT) Vs Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) in Transplant-Eligible Participants With Newly Diagnosed Multiple Myeloma",
"has_exemption": false,
"start_date": "2026-06-05",
"completion_date": "2038-05-21",
"has_results": false,
"results_due": false,
"sponsor_name": "Regeneron Pharmaceuticals",
"sponsor_slug": "regeneron-pharmaceuticals",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03989947",
"publication_url": "https://clinicaltrials.gov/study/NCT03989947",
"title": "A Phase 2 Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children With Achondroplasia",
"has_exemption": false,
"start_date": "2019-06-12",
"completion_date": "2038-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BioMarin Pharmaceutical",
"sponsor_slug": "biomarin-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03538899",
"publication_url": "https://clinicaltrials.gov/study/NCT03538899",
"title": "Phase I/II Safety and Efficacy Study of Gene Transfer for Artemis-Deficient Severe Combined Immunodeficiency (ART-SCID) in Newly Diagnosed Patients Using Self-Inactivating Lentiviral Vector (AProArt) to Transduce Autologous CD34 Hematopoietic Cells",
"has_exemption": false,
"start_date": "2018-05-31",
"completion_date": "2038-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "University of California, San Francisco",
"sponsor_slug": "university-of-california-san-francisco",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT00912041",
"publication_url": "https://clinicaltrials.gov/study/NCT00912041",
"title": "BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia",
"has_exemption": false,
"start_date": "2009-05-31",
"completion_date": "2038-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Leigh R. Hochberg, MD, PhD.",
"sponsor_slug": "leigh-r-hochberg-md-phd",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT04081701",
"publication_url": "https://clinicaltrials.gov/study/NCT04081701",
"title": "68Ga(Gallium)-DOTATATE Positron Emission Tomography (PET)/MRI in the Diagnosis and Management of Somatostatin Receptor Positive Central Nervous System CNS Tumors.",
"has_exemption": false,
"start_date": "2019-09-04",
"completion_date": "2038-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Weill Medical College of Cornell University",
"sponsor_slug": "weill-medical-college-of-cornell-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05929807",
"publication_url": "https://clinicaltrials.gov/study/NCT05929807",
"title": "A Phase 2, Multicenter, Long-Term, Open Label Extension Trial Evaluating Safety, Tolerability, and Efficacy of Subcutaneous Doses of TransCon CNP Administered Once Weekly in Children and Adolescents With Achondroplasia",
"has_exemption": false,
"start_date": "2023-06-21",
"completion_date": "2039-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Ascendis Pharma Growth Disorders A/S",
"sponsor_slug": "ascendis-pharma-growth-disorders-as",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07226388",
"publication_url": "https://clinicaltrials.gov/study/NCT07226388",
"title": "Hemiarthroplasty Versus Total Shoulder Arthroplasty for the Treatment of Glenohumeral Osteoarthritis: The Impact of Modern Implant Options",
"has_exemption": false,
"start_date": "2026-02-03",
"completion_date": "2039-02-28",
"has_results": false,
"results_due": false,
"sponsor_name": "Washington University School of Medicine",
"sponsor_slug": "washington-university-school-of-medicine",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06582745",
"publication_url": "https://clinicaltrials.gov/study/NCT06582745",
"title": "Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib",
"has_exemption": false,
"start_date": "2024-06-24",
"completion_date": "2039-06-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Cook Children's Health Care System",
"sponsor_slug": "cook-childrens-health-care-system",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06498635",
"publication_url": "https://clinicaltrials.gov/study/NCT06498635",
"title": "Randomized Phase III Trial INcorporating Pathologic Complete ReSponse in Participants With Early StaGe Non Small Cell Lung Cancer to Optimize ImmunotHerapy in The AdjuvanT Setting (INSIGHT)",
"has_exemption": false,
"start_date": "2025-04-01",
"completion_date": "2039-07-15",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06652633",
"publication_url": "https://clinicaltrials.gov/study/NCT06652633",
"title": "A Long-term Follow-up Study for Patients Treated With Galapagos CAR T-cell Therapies",
"has_exemption": false,
"start_date": "2024-09-09",
"completion_date": "2039-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Lakefront Biotherapeutics NV",
"sponsor_slug": "lakefront-biotherapeutics-nv",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06598371",
"publication_url": "https://clinicaltrials.gov/study/NCT06598371",
"title": "A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors",
"has_exemption": false,
"start_date": "2024-11-21",
"completion_date": "2039-08-01",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT04208529",
"publication_url": "https://clinicaltrials.gov/study/NCT04208529",
"title": "A Long-term Follow-up Study of Subjects With β-thalassemia or Sickle Cell Disease Treated With Autologous CRISPR-Cas9 Modified Hematopoietic Stem Cells (CTX001)",
"has_exemption": false,
"start_date": "2021-01-20",
"completion_date": "2039-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Vertex Pharmaceuticals Incorporated",
"sponsor_slug": "vertex-pharmaceuticals-incorporated",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT07431827",
"publication_url": "https://clinicaltrials.gov/study/NCT07431827",
"title": "A Phase 3, Randomized, Double-blind Study of Adjuvant MK-1084 Plus Subcutaneous Pembrolizumab and Berahyaluronidase Alfa (MK-3475A) Versus Adjuvant Placebo Plus MK-3475A in Participants With Completely Resected Stage IIA-IIIB (N2), KRAS G12C-mutant Non-small Cell Lung Cancer Following Receipt of Either Neoadjuvant Pembrolizumab Plus Chemotherapy or Adjuvant Chemotherapy (KANDLELIT-013)",
"has_exemption": false,
"start_date": "2026-03-18",
"completion_date": "2039-10-26",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02598349",
"publication_url": "https://clinicaltrials.gov/study/NCT02598349",
"title": "A Phase II Trial of Escalated Dose Proton Radiotherapy With Elective Nodal Irradiation and Concomitant Chemotherapy for Patients With Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma",
"has_exemption": false,
"start_date": "2016-04-30",
"completion_date": "2039-10-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Proton Collaborative Group",
"sponsor_slug": "proton-collaborative-group",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT06617286",
"publication_url": "https://clinicaltrials.gov/study/NCT06617286",
"title": "MAC-CAR: A Phase 1B/II Trial of Myeloablative Conditioning and Autologous Stem Cell Transplantation Followed by Autologous CD30+ CAR T Cells in Children, Adolescents and Young Adults With Poor-Risk Classical Hodgkin Lymphoma (cHL)",
"has_exemption": false,
"start_date": "2026-12-01",
"completion_date": "2039-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "New York Medical College",
"sponsor_slug": "new-york-medical-college",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03007589",
"publication_url": "https://clinicaltrials.gov/study/NCT03007589",
"title": "Natural Sunlight Protection and Simulated Sunlight Protection Offered by Sunscreens and Fabrics",
"has_exemption": false,
"start_date": "2014-04-30",
"completion_date": "2040-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Sun Protection Foundation",
"sponsor_slug": "sun-protection-foundation",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT05568719",
"publication_url": "https://clinicaltrials.gov/study/NCT05568719",
"title": "A PHASE 3, NON-INVESTIGATIONAL PRODUCT, MULTI COUNTRY COHORT STUDY TO DESCRIBE THE LONG-TERM SAFETY AND EFFECTIVENESS OF A PRIOR SINGLE-DOSE TREATMENT WITH INVESTIGATIVE GIROCTOCOGENE FITELPARVOVEC OR FIDANACOGENE ELAPARVOVEC IN PARTICIPANTS WITH HEMOPHILIA A OR HEMOPHILIA B, RESPECTIVELY",
"has_exemption": false,
"start_date": "2022-12-28",
"completion_date": "2040-02-25",
"has_results": false,
"results_due": false,
"sponsor_name": "Pfizer",
"sponsor_slug": "pfizer",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05849480",
"publication_url": "https://clinicaltrials.gov/study/NCT05849480",
"title": "A Phase I/II Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)",
"has_exemption": false,
"start_date": "2024-05-08",
"completion_date": "2040-06-01",
"has_results": false,
"results_due": false,
"sponsor_name": "National Cancer Institute (NCI)",
"sponsor_slug": "national-cancer-institute-nci",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05620771",
"publication_url": "https://clinicaltrials.gov/study/NCT05620771",
"title": "Phase II Study Therasphere® (Yttrium-90) in Combination With Systemic Therapy in Patients With High-risk Hepatocellular Carcinoma",
"has_exemption": false,
"start_date": "2022-11-30",
"completion_date": "2040-07-01",
"has_results": false,
"results_due": false,
"sponsor_name": "Northwestern University",
"sponsor_slug": "northwestern-university",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02689440",
"publication_url": "https://clinicaltrials.gov/study/NCT02689440",
"title": "Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Dasatinib and Venetoclax: A Phase II Study",
"has_exemption": false,
"start_date": "2016-02-19",
"completion_date": "2040-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07073014",
"publication_url": "https://clinicaltrials.gov/study/NCT07073014",
"title": "A Phase 3, Open-Label, Long-Term Extension Study to Evaluate the Safety and Efficacy of Vosoritide in Children With Hypochondroplasia",
"has_exemption": false,
"start_date": "2025-06-20",
"completion_date": "2040-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "BioMarin Pharmaceutical",
"sponsor_slug": "biomarin-pharmaceutical",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT02760849",
"publication_url": "https://clinicaltrials.gov/study/NCT02760849",
"title": "WISP (Women Choosing Surgical Prevention)",
"has_exemption": false,
"start_date": "2016-05-02",
"completion_date": "2041-05-31",
"has_results": false,
"results_due": false,
"sponsor_name": "M.D. Anderson Cancer Center",
"sponsor_slug": "md-anderson-cancer-center",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT07095452",
"publication_url": "https://clinicaltrials.gov/study/NCT07095452",
"title": "Phase 2/3, Multicenter, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Subjects With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant",
"has_exemption": false,
"start_date": "2026-01-08",
"completion_date": "2042-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "AbbVie",
"sponsor_slug": "abbvie",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT05962346",
"publication_url": "https://clinicaltrials.gov/study/NCT05962346",
"title": "Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion for Severe Left Congenital Diaphragmatic Hernia",
"has_exemption": false,
"start_date": "2026-12-31",
"completion_date": "2043-07-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Mauro H. Schenone",
"sponsor_slug": "mauro-h-schenone",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT03486873",
"publication_url": "https://clinicaltrials.gov/study/NCT03486873",
"title": "A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants Who Are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab",
"has_exemption": false,
"start_date": "2018-08-21",
"completion_date": "2043-08-04",
"has_results": false,
"results_due": false,
"sponsor_name": "Merck Sharp & Dohme LLC",
"sponsor_slug": "merck-sharp-dohme-llc",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06281730",
"publication_url": "https://clinicaltrials.gov/study/NCT06281730",
"title": "Use of New Generation Fetoscopes in Pregnancies Affected by Fetal Diseases Amenable to Fetoscopy Therapy",
"has_exemption": false,
"start_date": "2024-03-23",
"completion_date": "2044-02-29",
"has_results": false,
"results_due": false,
"sponsor_name": "Mayo Clinic",
"sponsor_slug": "mayo-clinic",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT06358638",
"publication_url": "https://clinicaltrials.gov/study/NCT06358638",
"title": "Sickle Cell Disease Transplant Using a Nonmyeloablative Approach: Adding Daratumumab for Patients With Anti-donor Red Cell AntibodY",
"has_exemption": false,
"start_date": "2024-04-03",
"completion_date": "2044-09-30",
"has_results": false,
"results_due": false,
"sponsor_name": "Children's National Research Institute",
"sponsor_slug": "childrens-national-research-institute",
"status": "ongoing",
"is_pact": false,
"days_late": null
},
{
"registry_id": "NCT01538056",
"publication_url": "https://clinicaltrials.gov/study/NCT01538056",
"title": "Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Juxtarenal Aortic Aneurysm: An Investigator Initiated Study",
"has_exemption": false,
"start_date": "2011-03-31",
"completion_date": "2045-01-31",
"has_results": false,
"results_due": false,
"sponsor_name": "University of Washington",
"sponsor_slug": "university-of-washington",
"status": "ongoing",
"is_pact": true,
"days_late": null
},
{
"registry_id": "NCT02917460",
"publication_url": "https://clinicaltrials.gov/study/NCT02917460",
"title": "Genomic Biorepository: Protocol for the Collection, Storage, Analysis, and Distribution of Biological Samples, Genomic and Clinical Data",
"has_exemption": false,
"start_date": "2016-07-31",
"completion_date": "2050-12-31",
"has_results": false,
"results_due": false,
"sponsor_name": "Rady Pediatric Genomics & Systems Medicine Institute",
"sponsor_slug": "rady-pediatric-genomics-systems-medicine-institute",
"status": "ongoing",
"is_pact": true,
"days_late": null
}
]
}